abstract |
The following general formula: A- (B) b0- (C) c0 -NO 2 (A is a group of the precursor drug selected between salicylic acid or acetylsalicylic acid, and B and C are divalent linking groups as defined in the present invention) Use of a compound or a salt thereof for treating vascular disease. |